Notice2022-10991
Proposed Data Collection Submitted for Public Comment and Recommendations
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
May 23, 2022
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Abstract
The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other federal agencies the opportunity to comment on a continuing information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project titled National Disease Surveillance Program. This collection covers the surveillance activities for four rare disease conditions; Creutzfeldt-Jakob Disease (CJD), Reye Syndrome, Kawasaki Syndrome, and Acute Flaccid Myelitis (AFM).
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 99 (Monday, May 23, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 99 (Monday, May 23, 2022)]
[Notices]
[Pages 31237-31238]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-10991]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-22-0009; Docket No. CDC-2022-0069]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
federal agencies the opportunity to comment on a continuing information
collection, as required by the Paperwork Reduction Act of 1995. This
notice invites comment on a proposed information collection project
titled National Disease Surveillance Program. This collection covers
the surveillance activities for four rare disease conditions;
Creutzfeldt-Jakob Disease (CJD), Reye Syndrome, Kawasaki Syndrome, and
Acute Flaccid Myelitis (AFM).
DATES: CDC must receive written comments on or before July 22, 2022.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2022-
0069 by either of the following methods:
<bullet> Federal eRulemaking Portal: <a href="http://www.regulations.gov">www.regulations.gov</a>. Follow
the instructions for submitting comments.
<bullet> Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS H21-8, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without
[[Page 31238]]
change, all relevant comments to <a href="http://www.regulations.gov">www.regulations.gov</a>.
Please note: Submit all comments through the Federal eRulemaking
portal (<a href="http://regulations.gov">regulations.gov</a>) or by U.S. mail to the address listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS H21-8, Atlanta, Georgia 30329; Telephone: 404-639-7570;
Email: <a href="/cdn-cgi/l/email-protection#640b0906240700074a030b12"><span class="__cf_email__" data-cfemail="5d32303f1d3e393e733a322b">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected; and
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses; and
5. Assess information collection costs.
Proposed Project
National Disease Surveillance Program (OMB Control No. 0920-0009,
Exp. 8/31/2022)--Revision--National Center for Emerging and Zoonotic
Infectious Diseases (NCEZID), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
Surveillance of the incidence and distribution of disease has been
an important function of the U.S. Public Health Service (PHS) since an
1878 Act of Congress authorized the PHS to collect morbidity reports.
After the Malaria Control in War Areas Program had fulfilled its
original 1942 objective of reducing malaria transmission, its basic
tenets were carried forward and broadened by the formation of the
Communicable Disease Center (CDC) in 1946. CDC was conceived of as a
well-equipped, broadly staffed agency used to translate facts about
analysis of morbidity and mortality statistics on communicable diseases
and through field investigations. It was soon recognized that control
measures (such as the DDT spraying for malaria) did not alleviate the
threat of disease reintroduction. In 1950, the Malaria Surveillance
Program began and in 1952, the National Surveillance Program started.
Both programs were based on the premise that diseases cannot be
diagnosed, prevented, or controlled until existing knowledge is
expanded and new ideas developed and implemented. The original scope of
the National Surveillance Program included the study of malaria, murine
typhus, smallpox, psittacosis, diphtheria, leprosy, and sylvatic
plague. Over the years, the mandate of CDC has broadened in preventive
health activities and the surveillance systems maintained have
expanded.
The National Disease Surveillance Program is authorized under the
Public Health Service Act, Section 301 and 306 (42 U.S.C. 241 and
242K). This information collection activity covers surveillance
activities for four, rare diseases: (1) Creutzfeldt-Jakob Disease
(CJD), (2) Reye Syndrome, (3) Kawasaki Syndrome, and (4) Acute Flaccid
Myelitis. Since the previous approval of 0920-0009, changes are being
requested only to the Acute Flaccid Myelitis form. The total estimated
burden requested by CDC has been reduced to 98, down 69 hours from the
previous total of 167, and is adjusted to match actual, experienced
burden more closely. There is no cost to respondents other than the
time to participate.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response Total burden
respondents respondent (in hours) (in hours)
----------------------------------------------------------------------------------------------------------------
Epidemiologist................ CJD............. 10 2 20/60 7
Kawasaki 20 2 15/60 10
Syndrome.
Reye Syndrome1.. 1 1 20/60 1
Acute Flaccid 100 4 12/60 80
Myelitis.
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 98
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2022-10991 Filed 5-20-22; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on May 23, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.